NGeneBio Co., Ltd. (KOSDAQ:354200)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,845.00
+108.00 (6.22%)
Last updated: May 12, 2025

NGeneBio Revenue

In the year 2024, NGeneBio had annual revenue of 5.69B KRW with 30.80% growth. NGeneBio had revenue of 716.54M in the quarter ending December 31, 2024, a decrease of -40.39%.

Revenue
5.69B
Revenue Growth
+30.80%
P/S Ratio
6.62
Revenue / Employee
n/a
Employees
n/a
Market Cap
37.66B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20245.69B1.34B30.80%
Dec 31, 20234.35B-6.67B-60.51%
Dec 31, 202211.02B3.85B53.81%
Dec 31, 20217.16B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition